The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
UMC Utrecht
ViroMissile, Inc.
AstraZeneca
Duke University
Washington University School of Medicine
Tizona Therapeutics, Inc